Tags: Chemical Compound, Chemical Substance.

Diquafosol (tradename: Diquas) is a pharmaceutical drug for the treatment of dry eye disease. It was approved for use in Japan in 2010 and in the United States it is in Phase III clinical trials. It is formulated as a 3% ophthalmic solution of the tetrasodium salt.Its mechanism of action involves agonism of the P2Y2 purinogenic receptor.

Diquafosol.svg
IUPAC name
[[(2R3S4R5R)-5-(24-Dioxopyrimidin-1-yl)-34-dihydroxy-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl] [(2R3S4R5R)-5-(24-dioxopyrimidin-1-yl)-34-dihydroxy-tetrahydrofuran-2-yl]methyl hydrogen phosphate

Loading...

This page contains content from the copyrighted Wikipedia article "Diquafosol"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.